So as of launch, the covered medications include Orforglipron, which is brand name Foundayo, which is a newer oral GLP-1 agonist, semaglutide, available as either the oral tablets or the subcutaneous injection, branded as Wegovy, and then tirzepatide, but specifically the multi-dose pen, which is the Zepbound KwikPen
Start your intake Why GLP-1 Medications Require Special Consideration in Crohn's Disease Crohn's disease involves chronic inflammation of the entire gastrointestinal tract, making patients sensitive to new medications that affect gut motility, appetite, or digestive function
One of the most interesting properties of glutathione is its ability to influence which type of melanin your cells produce
That's up from $5.3 billion in profit for the third quarter of 2022, according to the earnings report
No episodes of severe hypoglycemia were reported, and discontinuation due to adverse events occurred in 4.4% to 7.8% of patients on orforglipron, compared with 1.4% in the placebo group